Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salamat Parmoon Amin is a private pharmaceutical company based in Iran, specializing in the production of generic oral solid dosage medications. Established in 2012, the company operates a modern manufacturing facility in the Eshtehard Industrial Town that adheres to international Good Manufacturing Practice (GMP) standards. Its extensive product portfolio includes treatments for cardiovascular diseases, metabolic disorders, and central nervous system conditions. The company focuses on providing high-quality, cost-effective therapeutic options to the Iranian healthcare system and is actively expanding its reach into regional export markets. Through its commitment to research and development, Salamat Parmoon Amin continues to introduce new generic formulations to address unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salamat Parmoon Amin.